Joint Drugs Controller Dr. S. Eswara Reddy has been appointed as the new Drugs Controller General of India (DCGI) on February 20, 2018 for the next three months till regularly appointed person takes charge. According to a circular issued by the Ministry of Health and Family Welfare.
Dr. Reddy has obtained his Masters Degree in Pharmacy from College of Pharmaceuticals Sciences Manipal in 1994 and a PhD from JNTU, Hyderabad in 2009. He has experience in pharmaceutical manufacturing, academics and regulations.
He started his career as a Drugs Inspector in CDSCO, West Zone, Mumbai in 1998 and has good experience in GMP, GCP and GLP audits. He was promoted as Assistant Drugs Controller of India in 2009. He has participated in many national and international seminars, workshops and meetings on various areas of drugs regulations and undergone training from USFDA, KFDA, South Korea and WHO, Geneva.
He was invited to make presentations at various seminars and workshops. He got Best Drugs Inspector award in 2005 and Distinguished Alumni Award from Manipal Academy of Higher Education, Manipal.
Dr. Reddy has been awarded with appreciation letters from his superiors for effective implementation of drug regulations. He also published articles in various journals.
During his tenure at the headquarters of the Central Drugs Standard Control Organisation (CDSCO), Dr Reddy actively participated in formulating Drugs and Cosmetics Amendment Bill 2013, involved in strengthening Indian drug regulatory system during 12th Five Year Plan, streamlined medical devices division and handled international matters such as MoU, SOI and quality issues.